We turn American Heart Association's Science News into an interactive format for you. Find something interesting or have a question? Let us know in the comments.

Latest Posts

Archive for April, 2011
The Power of Play: Innovations in Getting Active Summit 2011

Circ Journal Cover for Science News

 

  • Insights are given as to how AHA is identifying new ways for Americans to be more physically active.
  • Scientific discussions on translating trends, future directions, and research for game designs are presented.
  • Active-play video games may improve physical exertion and help build confidence, social relationships, and skills for a physically active lifestyle.

    Read the full article in Circulation
  more...
Posted by Stacy AHA Science on Apr 26, 2011 12:32 PM CDT
ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly:
A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents


Circ Journal Cover for Science News

 

  • Hypertension in the elderly is a complex cardiovascular disorder.
  • Our population is aging, and more elderly patients have hypertension.
  • Hypertension in the elderly is underdiagnosed and undertreated.

    Read the full article in Circulation
  more...
Posted by Stacy AHA Science on Apr 25, 2011 3:51 PM CDT

Triglycerides and Cardiovascular Disease

CIR-July-8-C1_77x101
  • This is a comprehensive review devoted to triglycerides and looking at hyperlipidemia with attention to special populations.
  • Guidance is given for clinicians and patients on triglyceride lowering and dietary and lifestyle factors.
  • Effects of triglyceride metabolism and related disease outcomes are described.

    Read the full article in Circulation
  more...
Posted by Stacy AHA Science on Apr 18, 2011 6:11 PM CDT
c9090c38aadeb543ab9cc7224b361cb6-original-scinews_topadanceshbpr4.jpg


Top Research Advances in 2010 from the High Blood Pressure Research (HBPR) Council and the Council on the Kidney in Cardiovascular Disease (KCVD)  

The mission of the American Heart Association's Council for High Blood Pressure Research (HBPR) is to foster excellence in high blood pressure research and education and achieve the association's objectives in the field of hypertension.

The HBPR Council holds an annual international scientific conference for presentations on basic and clinical hypertension research. The fall conference presentations are published in the American Heart Association's journal Hypertension.

The mission of the American Heart Association's Council on the Kidney in Cardiovascular Disease is to reduce cardiovascular-related disability and death through research, communication, advocacy and education about the kidney.

Kidney disease is a major cause and a consequence of cardiovascular disease. Chronic renal insufficiency is thought to be an independent risk factor for developing hypertension, vascular disease, atherosclerosis and other morbidity and mortality risk factors. Patients with cardiovascular disease and diabetes are also at high risk for developing kidney failure.

Annually AHA asks all of its Councils and science groups what, in their opinion, have been the most important advances in their respective fields within the past year. The top advances relevant to the HBPR and KCVD communities, and the potential for these advances to impact the diverse field of cardiology for patients are discussed below.

  more...
Posted by Melissa AHA Science on Apr 6, 2011 12:55 PM CDT
AF Clinic: Specialised Atrial Fibrillation Clinic Reduces Cardiovascular Morbidity and Mortality in Patients with Atrial Fibrillation

Jeroen M. Hendriks, MD, PhD
Maastricht University Medical Centre, Maastricht, The Netherlands

*   *   *

Supporting Materials:
Presentation Slides | Summary Slide

Comments?  Leave them below.

View the latest AHA Science News coverage from ACC 2011 more...
Posted by Molly AHA Science on Apr 5, 2011 3:29 PM CDT
Baroreflex Activation Therapy Sustainably Lowers Blood Pressure in Patients with Resistant Hypertension: Results from the Rheos Pivotal Trial

John D. Bisognano, MD, PhD
University of Rochester medical Center, Rochester, NY
University of Chicago, Chicago, IL

*   *   *

Supporting Materials:
Presentation Slides | Summary Slide

Comments?  Leave them below.

View the latest AHA Science News coverage from ACC 2011 more...
Posted by Molly AHA Science on Apr 5, 2011 3:25 PM CDT
Targeted Left Ventricular Lead Placemetn to Guide Cardiac Resynchronization Therapy in Patients with Heart Failure: A Randomised Prospective Study (TARGET Study)

Fakhar Z. Khan, MD
Addenbrooke's Hospital, Cambridge, UK
Papworth Hospital, Cambridge, UK

*   *   *

Supporting Materials:
Presentation Slides | Summary Slide

Comments?  Leave them below.

View the latest AHA Science News coverage from ACC 2011 more...
Posted by Molly AHA Science on Apr 5, 2011 3:21 PM CDT
The Randomized Comparison of Six-Month versus 12-Month Duration of Dual Antiplatelet Therapy after Implantation of Drug Eluting Stent: From Comparison of Everolimusversus Sirolimus-Eluting Stents for Coronary Revascularization (EXCELLENT) Trial

Hyeon-Cheol Gwon, MD, PhD
On behalf of EXCELLENT Investigators
Samsung Medical Center, Seoul, South Korea
Seoul National University Hospital, Seoul, South Korea

*   *   *

Supporting Materials:
Presentation Slides | Summary Slide

Comments?  Leave them below.

View the latest AHA Science News coverage from ACC 2011 more...
Posted by Molly AHA Science on Apr 5, 2011 3:13 PM CDT
Selective Inhibition of Delta Protein Kinase C to Reduce Infarct Size after Primary Percutaneous Intervention for Acute Myocardial Infarction: The PROTECTION-AMI Phase IIb Clinical Trial

A. Michael Lincoff, MD
Cleveland Clinic, Cleveland, OH

*   *   *

Supporting Materials:
Presentation Slides | Summary Slide

Comments?  Leave them below.

View the latest AHA Science News coverage from ACC 2011 more...
Posted by Molly AHA Science on Apr 5, 2011 3:08 PM CDT
The Comparison of High-dose Angiotensin II Receptor Blocker (ARB) Monotherapy Versus Combination Therapy of ARB with Calcium Channel Blocker on Cardiovascular Events in Japanese Elderly High-Risk Hypertensive Patients: Olmesartan and Calcium Antagonists Randomized (OSCAR) Study

Hisao Ogawa, MD, PhD
Fukuoka University, Fukuoka, Japan

*   *   *

Supporting Materials:
Presentation Slides| Summary Slide | Video Interview

Comments?  Leave them below.

View the latest AHA Science News coverage from ACC 2011 more...
Posted by Molly AHA Science on Apr 5, 2011 3:04 PM CDT
< Prev    1 2 3   

Most Recent Comments

My husband had a heart attack in hospital 2 days after colon surgery and the code team did not use defib machine or padd...
We have some interesting data coming in post pre-participation sports screening clinic. We performed the clinic l...
Title: Latest Findings on the Health Effects of Coffee on Heart & BrainContents: nothing to do with coffee
As a cardiologist with current board-certification in critical care, I hope to help move this initiative forward....